publication venue for Solid amorphous formulations for enhancing solubility and inhibiting Erlotinib crystallization during gastric-to-intestinal transfer. 28:697-707. 2023 Comparison study of physicochemical and biopharmaceutics properties of hydrophobic drugs ground by two dry milling processes. 27:816-828. 2022
